Ownership

Michael E. Kamarck

Insider Reports History

Entity: Individual
Location: C/O Unilife Corporation, 250 Cross Farm Lane, York, PA
Signature: Michael E. Kamarck, by /s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael E. Kamarck:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Vaxcyte, Inc.	Director	Common Stock	5.63K	$364K	$64.78	Jun 13, 2023	Direct
Passage BIO, Inc.	Director	Director Stock Option (Right to Buy)	21.6K			May 25, 2023	Direct
Vaxcyte, Inc.	Director	Stock Option (right to buy)	15K			Jun 13, 2023	Direct
Trillium Therapeutics Inc.	Director	Stock Option (Right to Buy)	0			Nov 17, 2021	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by Michael E. Kamarck

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
PCVX	Vaxcyte, Inc.	Jun 13, 2023	2	$0	4	Jun 15, 2023	Director
PASG	Passage BIO, Inc.	May 25, 2023	1	$0	4	May 26, 2023	Director
PASG	Passage BIO, Inc.	Jul 5, 2022	1	$0	4	Jul 6, 2022	Director
PASG	Passage BIO, Inc.	Jul 2, 2022	0	$0	3	Jul 6, 2022	Director
PCVX	Vaxcyte, Inc.	Jun 1, 2022	2	$0	4	Jun 3, 2022	Director
TRIL	Trillium Therapeutics Inc.	Nov 17, 2021	1	$0	4	Nov 19, 2021	Director
PCVX	Vaxcyte, Inc.	Oct 27, 2021	1	$0	4	Oct 29, 2021	Director
PCVX	Vaxcyte, Inc.	Oct 27, 2021	0	$0	3	Oct 29, 2021	Director